Cargando…
Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review
BACKGROUND: In the past two decades, subanaesthetic doses of ketamine have been demonstrated to have rapid and sustained antidepressant effects, and accumulating research has demonstrated ketamine's therapeutic effects for a range of psychiatric conditions. AIMS: In light of these findings surr...
Autores principales: | Walsh, Zach, Mollaahmetoglu, Ozden Merve, Rootman, Joseph, Golsof, Shannon, Keeler, Johanna, Marsh, Beth, Nutt, David J., Morgan, Celia J. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715255/ https://www.ncbi.nlm.nih.gov/pubmed/35048815 http://dx.doi.org/10.1192/bjo.2021.1061 |
Ejemplares similares
-
Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review – CORRIGENDUM
por: Walsh, Zach, et al.
Publicado: (2022) -
“This Is Something That Changed My Life”: A Qualitative Study of Patients' Experiences in a Clinical Trial of Ketamine Treatment for Alcohol Use Disorders
por: Mollaahmetoglu, O. Merve, et al.
Publicado: (2021) -
Safety and tolerability of intramuscular and sublingual ketamine for psychiatric treatment in the Roots To Thrive ketamine-assisted therapy program: a retrospective chart review
por: Tsang, Vivian W.L., et al.
Publicado: (2023) -
Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls
por: Rootman, Joseph M., et al.
Publicado: (2022) -
Author Correction: Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls
por: Rootman, Joseph M., et al.
Publicado: (2022)